Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 2, 2015, Pages

  Ker, Katharine ^a   Tansley, Gavin ^a   Beecher, Deirdre ^a   Perner, Anders ^b   Shakur, Haleema ^a   Harris, Tim ^c   Roberts, Ian ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Rigshospitalet   (Denmark)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; INFUSION FLUID; POTASSIUM; SODIUM; UREA;

AGITATION; COMPARATIVE STUDY; EBOLA HEMORRHAGIC FEVER; EDEMA; ERYTHEMA; HUMAN; INFECTION; MORTALITY; NEEDLESTICK INJURY; OUTCOME ASSESSMENT; PAIN; PARENTERAL DRUG ADMINISTRATION; PHLEBITIS; PHYSICIAN ATTITUDE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELIABILITY; REVIEW; RISK; SODIUM BLOOD LEVEL; SWELLING; SYSTEMATIC REVIEW; THERAPY EFFECT; COMPLICATION; DEHYDRATION; DISEASE MANAGEMENT; HYPODERMOCLYSIS; INFUSION; INTRAOSSEOUS DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; PROCEDURES; SAPHENOUS VEIN;

DEHYDRATION; DISEASE MANAGEMENT; HEMORRHAGIC FEVER, EBOLA; HUMANS; HYPODERMOCLYSIS; INFUSIONS, INTRAOSSEOUS; INFUSIONS, INTRAVENOUS; INFUSIONS, PARENTERAL; SAPHENOUS VEIN;

EID: 84964693642     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD011386.pub2     Document Type: Review

References (54)

1. Banerjee S, Singhi S, Singh SC, Singh M. The intraosseous route is a suitable alternative to intravenous route for fluid resuscitation in severely dehydrated children. Indian Pediatrics 1994;31(12):1511-20.
2. Boullu-Sanchis S, Ortega F, Chabrier G, Busch MS, Uhl C, Pinget M, et al. Efficacy of short term continuous subcutaneous insulin lispro versus continuous intravenous regular insulin in poorly controlled, hospitalized, type 2 diabetic patients. Diabetes & Metabolism 2006;32(4):350-7.
3. Challiner YC, Jarrett D, Hayward MJ, al-Jubouri MA, Julious SA. A comparison of intravenous and subcutaneous hydration in elderly acute stroke patients. Postgraduate Medical Journal 70;821:195-7.
4. Dardaine V, Garrigue MA, Rapin CH, Constans T. Metabolic and hormonal changes induced by hypodermoclysis of glucose-saline solution in elderly patients. Journals of Gerontology Series A-Biological Sciences & Medical Sciences 1995;50(6):M334-6.
5. Delamaire D, Meigne B, Lecoq A, Cattenoz C, Michel M, Miche O. A rehydration randomized trial favoring the subcutaneous route in the elderly [Un essai controle d'hydratation en faveur d'une actualisation de l'hypodermoclyse chez le sujet age]. Revue de Medecine Interne 1992;13(7):S321.
6. Duems Noriega O, Arino Blasco S. Efficacy of the subcutaneous route compared to intravenous hydration in the elderly hospitalised patient: a randomised controlled study. Revista Espanola de Geriatria y Gerontologia 2014;49(3):103-7.
7. Hägglund H, Ringdén O, Agren B, Wennberg L, Remberger M, Rundquist L, et al. Intraosseous compared to intravenous infusion of allogeneic bone marrow. Bone Marrow Transplantation 1998;21(4):331-5.
8. Harbo T, Andersen H, Hess A, Hansen K, Sindrup SH, Jakobsen J. Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single-blinded cross-over trial. European Journal of Neurology 2009;16(5):631-8.
9. Harvey VJ, Slevin ML, Aherne GW, Littleton P, Johnston A, Wrigley PF. Subcutaneous infusion of bleomycin--a practical alternative to intravenous infusion. Journal of Clinical Oncology 1987;5(4):648-50.
10. Hubble MW, Trigg DC. Training prehospital personnel in saphenous vein cutdown and adult intraosseous access techniques. Prehospital Emergency Care 2001;5(2):181-9.
11. Lamhaut L, Dagron C, Apriotesei R, Gouvernaire J, Elie C, Marx JS, et al. Comparison of intravenous and intraosseous access by pre-hospital medical emergency personnel with and without CBRN protective equipment. Resuscitation 2010;81(1):65-8.
12. Lamhaut L, Dagron C, Apriotesei R, Gouvernaire J, Elie C, Marx JS, et al. Comparison of intravenous and intraosseous access by pre-hospital medical emergency personnel with and without CBRN protective equipment. Resuscitation 2010;81(1):65-8.
13. Liebl A, Hoogma R, Renard E, Geelhoed-Duijvestijn PH, Klein E, Diglas J, et al. A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion. Diabetes, Obesity & Metabolism 2009;11(11):1001-8.
14. O'Keeffe ST, Lavan JN. Subcutaneous fluids in elderly hospital patients with cognitive impairment. Gerontology 1996;42(1):36-9.
15. Reades R, Studnek JR, Vandeventer S, Garrett J. Intraosseous versus intravenous vascular access during out-of-hospital cardiac arrest: a randomized controlled trial. Annals of Emergency Medicine 2011;58(6):509-16.
16. Selam JL, Slingeneyer A, Hedon B, Mares P, Beraud JJ, Mirouze J. Long-term ambulatory peritoneal insulin infusion of brittle diabetes with portable pumps: comparison with intravenous and subcutaneous routes. Diabetes Care 1983;6(2):105-11.
17. Slesak G, Schnurle JW, Kinzel E, Jakob J, Dietz PK. Comparison of subcutaneous and intravenous rehydration in geriatric patients: a randomized trial. Journal of the American Geriatrics Society 2003;51(2):155-60.
18. Spandorfer PR, Alessandrini EA, Joffe MD, Localio R, Shaw KN. Oral versus intravenous rehydration of moderately dehydrated children: a randomized, controlled trial. Pediatrics 2005;115:295-301.
19. Chavez-Negrete A, Majluf Cruz S, Frati Munari A, Perches A, Arguero R. Treatment of hemorrhagic shock with intraosseus or intravenous infusion of hypertonic saline dextran solution. European Surgical Research 1991;23(2):123-9.
20. Ismael G, Hegg R, Muehlbauer S, Heinzmann D, Lum B, Kim S, et al. Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I-III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial. Lancet Oncology 2012;13(9):869-78.
21. Klemenz BE. Subcutaneous versus intravenous rehydration therapy in older patients. Deutsche Medizinische Wochenschrift 1997;122(49):1540-1.
22. Koshy RC, Kuriakose R, Sebastian P, Koshy C. Continuous morphine infusions for cancer pain in resource-scarce environments: comparison of the subcutaneous and intravenous routes of administration. Journal of Pain & Palliative Care Pharmacotherapy 2005;19(1):27-33.
23. Lee Y, Koo J, Kim J, Park I, Joo M, Yoon J, et al. Effect of route of EPO administration on hemodialysis arteriovenous vascular access failure: a randomized controlled trial. American Journal of Kidney Diseases 2009;53(5):815-22.
24. Mace SE, Harb G, Friend K, Turpin R, Armstrong EP, Lebel F. Cost-effectiveness of recombinant human hyaluronidase-facilitated subcutaneous versus intravenous rehydration in children with mild to moderate dehydration. American Journal of Emergency Medicine 2013;31(6):928-34.
25. Mahalanabis D, Sack RB, Kaplan J, Jacobs B, Mondal A. Intraperitoneal fluid therapy in cholera and non-cholera diarrhoea: with special emphasis on the treatment of infants and children. Bulletin of the World Health Organization 1970;42(6):837-46.
26. Moulin DE, Kreeft JH, Murray-Parsons N, Bouquillon AI. Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain. Lancet 1991;337(8739):465-8.
27. Nelson KA, Glare PA, Walsh D, Groh ES. A prospective, within-patient, crossover study of continuous intravenous and subcutaneous morphine for chronic cancer pain. Journal of Pain & Symptom Management 1997;13(5):262-7.
28. Paxton JH, Knuth TE, Klausner HA. Proximal humerus intraosseous infusion: a preferred emergency venous access. Journal of Trauma 2009;67(3):606-11.
29. Rajani AK, Chitkara R, Oehlert J, Halamek LP. Comparison of umbilical venous and intraosseous access during simulated neonatal resuscitation. Pediatrics 2011;128(4):954-8.
30. Ransome-Kuti O, Elebute O, Agusto-Odutola T, Ransome-Kuti S. Intraperitoneal fluid infusion in children with gastroenteritis. British Medical Journal 1969;3(5669):500-3.
31. Robinson AM, McLean KA, Greaves M, Channer KS. Subcutaneous versus intravenous administration of heparin in the treatment of deep vein thrombosis; which do patients prefer? A randomized cross-over study. Postgraduate Medical Journal 1993;69(808):115-6.
32. Soremekun OA, Shear ML, Patel S, Kim GJ, Biddinger PD, Parry BA, et al. Rapid vascular glucose uptake via enzyme-assisted subcutaneous infusion: enzyme-assisted subcutaneous infusion access study. American Journal of Emergency Medicine 2009;27(9):1072-80.
33. Tighe SQ, Rudland SV, Kemp PM, Kershaw CR. Paediatric resuscitation in adverse circumstances: a comparison of three routes of systemic access. Journal of the Royal Naval Medical Service 1993;79(2):75-9.
34. Deeks JJ, Higgins JPT, Altman DG on behalf of the CSMG. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
35. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet 2011;377(9768):849-62.
36. Fowler RA, Fletcher T, Fischer WA II, Lamontagne F, Jacob S, Brett-Major D, et al. Caring for critically ill patients with ebola virus disease. Perspectives from West Africa. American Journal of Respiratory and Critical Care Medicine 2014;190(7):733-7.
37. McMaster University. GRADEpro. Hamilton, Ontario: McMaster University, 2014.
38. Higgins JPT, Altman DG, Sterne JAC on behalf of the CSMG and the CBMG. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
39. Higgins JPT, Deeks JJ, Altman DG on behalf of the CSMG. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
40. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Medical Research Methodology 2005;5:13. [DOI: 10.1186/1471-2288-5-13]
41. Kreuels B, Wichmann D, Emmerich P, Schmidt-Chanasit J, de Heer G, Kluge S, et al. A case of severe Ebola virus infection complicated by Gram-negative septicemia. New England Journal of Medicine 2014 Oct 22 [Epub ahead of print]. [DOI: 10.1056/NEJMoa1411677]
42. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
43. Remington R, Hultman T. Hypodermoclysis to treat dehydration: a review of the evidence. Journal of the American Geriatrics Society 2007;55:2051-5.
44. Ribner B. Ebola: Lessons Learned, from IDWeek 2014. http://www.idweek.org/ebola_idweek_2014/ (accessed 24 October 2014).
45. Rochon PA, Gill SS, Litner J, Fischbach M, Goodison AJ, Gordon M. A systematic review of the evidence for hypodermoclysis to treat dehydration in older people. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 1997;52(3):M169-76.
46. Rouhani S, Meloney L, Ahn R, Nelson BD, Burke TF. Alternative rehydration methods: a systematic review and lessons for resource-limited care. Pediatrics 2011;127(3):748-57.
47. Sanchez A, Geisbert TW, Feldmann H. Filoviridae: Marburg and Ebola viruses. In: Knipe DM, Howley PM editor(s). Fields Virology. 5th Edition. Philadelphia: Lippincott Williams & Wilkins, 2006:1409-48.
48. Schieffelin JS, Shaffer JG, Goba A, Gbakie M, Gire SK, Colubri A, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. New England Journal of Medicine 2014 Oct 29 [Epub ahead of print]. [DOI: 10.1056/NEJMoa1411680]
49. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
50. Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet. TSA - Trial Sequential Analysis 0.9 Beta. Copenhagen: Copenhagen Trial Unit, Center for Clinical Intervention Research, Rigshospitalet, 2011.
51. Waitt C, Waitt P, Pirmohamed M. Review: Intravenous therapy. Postgraduate Medical Journal 2004;80:1-6.
52. World Health Organization. Ebola virus disease: Fact sheet number 103 (updated September 2014). http://www.who.int/mediacentre/factsheets/fs103/en/ (accessed 24 October 2014).
53. WHO Ebola Response Team. Ebola virus disease in West Africa - the first 9 months of the epidemic and forward projections. New England Journal of Medicine 2014;371(16):1481-95.
54. Ker K, Tansley G, Beecher D, Perner A, Shakur H, Harris T, Roberts I. Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola Virus Disease. Cochrane Database of Systematic Reviews 2014, Issue 11. [DOI: 10.1002/14651858.CD011386]